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Расте бројот на научни докази за влијанието на метаболичкиот синдром (MetS) врз прогресијата на 
атеросклерозата, што ја наметнува потребата за истражувања на поврзаноста на MetS со каротидна 
артериска болест (CAD) како значаен ризик-фактор за цереброваскуларен инсулт (CVI) и транзиторна 
исхемична атака (TIA). Целта на овој труд беше да се утврди преваленцијата на CAD како ризик-фак-
тор за CVI и TIA кај испитаниците со MetS. Материјал и методи: Ова е студија на пресек во која беа 
вклучени 118 испитаници, 65 мажи, 53 жени, со MetS согласно NCEP ATP III критериумите. Пациентите 
беа анализирани клинички, биохемиски и ултрасонографски во ГОБ „8-ми Септември“ – Скопје во 
периодот од јануари 2017 до јануари 2018 година. Согласно стандардните рутински протоколи беа 
одредувани вредностите за обемот на половината, крвниот притисок, гликемијата, триглицеридите 
и HDL холестеролот. Евалуацијата на екстракранијалното каротидно стебло беше правена со Color 
Doppler Duplex сонографија со линеарна сонда со фреквенција од 7,5 MHz. Проценката на CAD беше 
направена со користење на ултразвучни консензус критериуми за каротидна стеноза. Објективната 
невролошка проценка за постоење на CVI и TIA се вршеше со невролошки преглед по стандарден 
протокол и со резултатите од КТМ од медицинската историја. Резултати: Вкупната преваленција на 
CAD кај сите испитаниците со MetS во оваа студија беше 77 испитаници (65,25%); од нив симптоматска 
CAD имаа 35 испитаници (29,66%) од кои 17 испитаници (48,57%) беа со CVI, а 18 испитаници (51,43%) беа 
со TIA. Во однос на степенот на каротидна артериска стеноза (CAS) кај вкупниот број испитаници со 
MetS и CAD не беа регистрирани испитаници со нормален наод; 16 испитаници имаа стеноза < 50% , 
29 испитаници имаа стеноза 50-69%, 23 испитаници имаа стеноза 70-99% , додека, пак,  оклузија имаа 
9 испитаници. Заклучок: Резултатите од оваа студија покажаа доминација на асимптоматска CAD кај 
испитаниците со MetS, со што дополнително се наметнува потребата за навремена екстракранијална 
ултрасонографска евалуација на каротидното стебло. Со тоа би се постигнала ефикасна превенција и 
адекватен третман на CVI и TIA, намалување на морбидитетот и морталитетот од цереброваскуларни 
настани што има големо здравствено и социоекономско значење. 
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There is a growing body of scientific evidence on the impact of metabolic syndrome (MetS) on the 
progression of atherosclerosis, imposing the need for research of the association of MetS with carotid 
artery disease (CAD) as a significant risk factor for cerebrovascular insult (CVI) and transient ischemic 
attack (TIA). The aim of the study was to determine the prevalence of CAD as a risk factor for CVI and 
TIA in subjects with MetS. Material and methods: A cross-sectional study was performed including a 
total of 118 subjects, 65 men, 53 women, with MetS according to NCEP ATP III criteria that were analyzed 
clinically, biochemically and ultrasonographically in the City General Hospital „8th September“ - Skopje 
in the period from January 2017 to January 2018. Waist circumference, blood pressure, glycemia, 
triglycerides, and HDL cholesterol were determined according to standard routine protocols. The 
evaluation of the extracranial carotid trunk was done with a Color Doppler Duplex sonography with 
a linear probe of 7.5MHz. CAD assessment was performed using Ultrasound Consensus Criteria for 
Carotid Stenosis. An objective neurological assessment of the existence of CVI and TIA was performed 
by a standard protocol for neurological examination and brain CT results from medical history were 
reviewed. Results: The prevalence of CAD in this study was 77 subjects (65.25%), of which 35 subjects 
(29.66%) had symptomatic CAD, 17 subjects (48.57%) had CVI, 18 subjects (51.43%) had TIA. Regarding the 
degree of carotid artery stenosis (CAS) in the total number of subjects with MetS and CAD, no subjects 
with normal findings were registered, 16 subjects had stenosis <50% , 29 subjects had stenosis 50-69% , 
23 subjects had stenosis 70-99% , while 9 subjects had occlusion. Conclusion: The results obtained in this 
study have shown that asymptomatic CAD is dominant in patients with MetS, which further imposed the 
need for timely extracranial ultrasonographic evaluation of the carotid trunk. This would achieve both 
effective prevention and adequate treatment of CVI and TIA, thereby reducing morbidity and mortality 
from cerebrovascular events which has a great health and socioeconomic significance.
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Introduction
The influence of the metabolic syndrome 
on the progression of atherosclerosis 
has been confirmed in the results of nu-
merous studies, which have also shown 
a correlation between carotid athero-
sclerosis and generalized atherosclero-
sis. Because of this, subjects with MetS 
are at an increased risk of developing 
carotid artery disease, cardio and cere-
brovascular disease, diabetes mellitus1. 
The underlying pathophysiology of MetS 
is obesity and insulin resistance, but it is 
more complicated and involves a num-
ber of other factors, including genetic 
and environmental factors2. Carotid ar-
tery disease (CAD) involves changes in 
the arterial wall that cause IMT to thick-
en, narrow or completely obstruct the 
carotid artery lumen. Atherosclerosis is 
the most common cause of CAD. Other 
non-atherosclerotic causes are rare and 
include carotid dissection, fibromuscu-
lar dysplasia, arteritis (Takayasu), radia-
tion, glomerular tumors on bifurcation, 
and trauma3. That is why atherosclerot-
ic extracranial CAD is included in this 
study. Selection sites for CAD are carotid 
bifurcation, the ACI ostium, including 
the posterior outer wall of the carotid 
sinus and the distal part of common ca-
rotid artery. CAD can be asymptomatic 
and symptomatic. Asymptomatic CAD is 
without clinical manifestation of brain 
suffering, whereas symptomatic CAD 
may manifest clinically as TIA or CVI. 
CVI is a medical condition in which poor 
blood flow to the brain results in the 
death of cells by initiating an ischemic 
cascade. TIA is a brief episode of neuro-
logical dysfunction with vascular cause, 
with clinical symptoms usually lasting 
less than an hour and without imaging 
evidence of infarction4. Disorders phe-
nomenology at CVI and TIA depends on 
which part of the brain is affected by 
ischemic suffering.
The aim of the study was to determine 
the prevalence of CAD as a risk factor for 
CVI and TIA in subjects with MetS.
Material and methods 
This cross-sectional study comprised a 
total of 118 subjects with MetS accord-
ing to NCEP ATP III (National Choles-
terol Education Program, Adult Treat-
ment Panel III) criteria, aged ≥ 30 and ≤ 
80 years, that were analyzed clinically, 
biochemically and ultrasonographi-
cally in the City General Hospital “8th 
September” - Skopje in the period from 
January 2017 to January 2018.
NCEP ATP III criteria - having any of 
the three or more of the following pa-
rameters: 
1. Abdominal obesity - increased 
waist circumference values ≥ 102 
cm (40 in), women ≥ 88 cm (35 in); 
2. Increased triglycerides ≥ 150 mg/
dL (1.69 mmol/L), or treatment for 
elevated triglycerides (e.g. fibrates 
or nicotinic acid); 
3. Decreased HDL cholesterol values 
for men <40 mg/dL (1.03 mmol/L), 
women <50 mg/dL (1.29 mmol/L), 
or medication treatment for lower 
HDL cholesterol levels (e.g. fibrates 
or nicotinic acid); 
4. Elevated blood pressure values: 
systolic ≥ 130 mmHg and / or dia-
stolic ≥ 85 mmHg; or treatment 
with hypertension medications; 
5. Elevated fasting blood glucose val-
ues ≥ 100 mg/dL (5.6 mmol/L); or 
treatment with antidiabetic drugs. 
Inclusion criteria: people with MetS 
according to NCEP ATP III criteria, age 
≥ 30 and ≤ 80 years. Exclusion criteria: 
individuals without MetS, pregnant 
women, nursing mothers, age <30 and 
>80. All participants were informed 
about the purpose of the research and 
an informed consent was obtained 
prior to the study.
MetS assessment was performed ac-
cording to NCEP ATP III (National 
Cholesterol Education Program, Adult 
Treatment Panel III). Waist circumfer-
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ence was measured at the end of the 
slow expirium with a soft, elastic band 
in the upright position of the subject 
at the midpoint between the upper 
edge of the iliac bone and the lower 
edge of the last rib. A mean of two 
blood pressure measurements with 
a standard sphygmomanometer was 
used after a short rest in the sitting 
position. In the main laboratory of 
CGH “8th September” - Skopje, venous 
blood samples were taken after an 
all-night starvation to assess the fol-
lowing parameters: fasting glycemia, 
triglycerides and high-density lipopro-
tein cholesterol (HDL-C). An objective 
neurological assessment of the exis-
tence of CVI and TIA was performed 
by a standard protocol for neurologi-
cal examination and brain CT results 
from medical history were reviewed. 
CAD evaluation was performed by an 
ultrasound scan of the extracranial 
carotid arteries with an Esaote MyLab 
™ 70 XVG, with a linear probe with a 
transmission frequency of 7.5 MHz, us-
ing B-mode, color and Doppler mode. 
CAD assessment was performed using 
Ultrasound Consensus Criteria for Ca-
rotid Stenosis: I. Absence of Stenosis 
(Normal Finding) - No Plaques, Normal 
IMT, PSV<125 cm/s, ACI/ACC Ratio of 
PSV <2, EDV <40 cm/s; 2. II Stenosis 
<50%: present plaque <50%, IMT thick, 
PSV <125 cm/s, ACI/ACC ratio of PSV 
<2, EDV <40 cm/s; III Stenosis <50-
69%: IMT thick, visible plaque> 50%, 
PSV 125-230 cm/s, ACI/ACC ratio of 
PSV 2-4, EDV 40-100 cm/s. IV Stenosis 
70% to subocclusive (up to 99%): visi-
ble narrowing > 50%, PSV> 230 cm/s, 
ACI/ACC ratio of PSV> 4, EDV> 100 
cm/s; V Subocclusion/near occlusion: 
significant visible narrowing; nearly 
occluded artery, PSV may be low or no 
detectable, ACI/ACC ratio of PSV vari-
able, EDV variable; VI Occlusion: no 
flow, lumen visible, PSV no flow, un-
detectable, ACI/ACC ratio of PSV not 
applicable, EDV not applicable.
The statistical analysis of data was per-
formed with the statistical program 
SPSS for Windows, 23.0. To compare 
the groups of subjects, the parameter 
tests (t-test for independent samples, 
analysis of variance) were used.
Results
The overall prevalence of CAD among 
subjects with MetS in this study was 
77 subjects (65.25%), The overall prev-
alence of CAD in terms of gender dis-
tribution was 36 women (30.51%) and 
41 men (34.75%) (Figure 1). Gender dis-
tribution showed no statistical signif-
icance (p = 0.24).
Figure 1.  Distribution of CAD by demographics of the study subjects
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Of the total number of subjects, 35 
subjects (29.66%) were with symptom-
atic CAD of which 17 subjects (48.57%) 
had CVI, 18 subjects (51.43%) had 
TIA, and the remaining 42 subjects 
(35.59%) were asymptomatic. 
Figure 2.  Prevalence of symptomatic and asymptomatic CAD
Table 1.  Degree of carotid artery stenosis (CAS) in symptomatic CAD
Figure 3.  Prevalence of CVI and TIA in symptomatic CAD
Regarding the degree of carotid artery 
stenosis (CAS) in the total number of 
subjects with MetS and CAD, there 
were no reported subjects with nor-
mal findings, 16 subjects had stenosis 
<50%, 29 subjects had stenosis 50-69%, 
23 subjects had stenosis 70-99%, and 9 
subjects had occlusion (Table1).
Degree of carotid artery stenosis (CAS) 
in the total number of subjects with 
MetS and CAD
(n) Number of patients
< 50% 16
50-69% 29
70-99% 23
Occlusion 9
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Discussion
Due to the rise in the prevalence of 
MetS as a worldwide phenomenon 
and the increase in morbidity 
and mortality from cardio- and 
cerebrovascular disease, numerous 
studies have been performed 
to establish the correlation 
between MetS and cardio- and 
cerebrovascular events. The results 
of these studies showed a clear and 
strong association between them. 
According to the study by Gorter 
et al., the prevalence of MetS was 
41% in subjects with coronary heart 
disease, 43% with cerebrovascular 
diseases, and 58% in patients with 
peripheral arterial disease5. Namely, 
the results of the study by Ninomiya 
JK et al. Has indicated a strong, 
consistent association of MetS with 
prevalence of myocardial infarction 
and stroke6. The association 
between generalized atherosclerosis 
and carotid atherosclerosis and its 
major influence on the occurrence of 
cerebrovascular events has also been 
confirmed and known. Symptomatic 
CAD implies the etiological 
association of CAD with TIA and 
CVI. This is especially important 
since more than 80% of all strokes 
are ischemic strokes and only 20% 
are intracerebral haemorrhage. Of 
all ischemic strokes, three-fourths 
occupy the anterior circulation, 
while one-quarter of the posterior 
cerebral circulation accounts for the 
rest of ischemic strokes7. Namely, 
about 20 - 25% of stroke patients 
have confirmed atherosclerosis of 
the large blood vessels in the neck 
that feed the brain, of which 85% 
are with CAD as a cause. There is a 
particularly increased risk of stroke 
in atherosclerotic stenotic lesions 
in the extracranial internal carotid 
artery or carotid bifurcation8. 
Similar results were obtained in our 
study; the overall prevalence of CAD 
among MetS subjects in this study 
was 65.25%, of which 29.66% had 
symptomatic CAD of which 48.57% 
had CVI, 51.43% were with TIA, and 
the rest were asymptomatic.
The prevalence of CAD varies with 
age and considerably depends 
on race. For all races the most 
important factor in the development 
of CAD is the increasing age. This 
has been confirmed by several 
studies, including the Los Angeles 
County General Hospital study9 and 
the Caron B. Rockman et al. study10. 
The results obtained from numerous 
CAD prevalence studies depend on 
the criteria applied, the research 
tools used, and the population 
covered. Thus, the prevalence of a 
significant carotid artery stenosis 
(50% ultrasound-diagnosed carotid 
stenosis) in the Framingham study 
was 9% in men and 7% in women11. 
The highest prevalence was reported 
in people with acute stroke (60%), 
then 18% in people with heart disease 
and 11% in people at increased risk 
for atherosclerosis12. There are 
numerous studies on the prevalence 
of moderate carotid stenosis that 
show heterogeneous data on adult and 
gender distribution. However, most 
of them show that the prevalence of 
moderate carotid stenosis is higher 
in men than in women and that the 
prevalence increases with age in 
both men and women13-16. In our 
study, similar results were found for 
the prevalence of CAD according to 
gender distribution that was higher 
in men than in women (34.75% vs. 
30.51%). Regarding the degree of 
stenosis in symptomatic CAD, no 
subjects with normal findings were 
registered, 16 subjects had stenosis 
<50%, 29 subjects had stenosis 50-
69% , 23 subjects had stenosis 70-99% 
, and 9 subjects had occlusion .
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Conclusion
The results obtained in this study 
have shown that asymptomatic CAD 
is dominant in patients with MetS, 
which further imposes the need for 
timely extracranial ultrasonographic 
evaluation of the carotid trunk. 
This would achieve both effective 
prevention and adequate treatment 
of CVI and TIA, thereby reducing 
morbidity and mortality from 
cerebrovascular events which has 
a great health and socioeconomic 
significance. 
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